Vitamin D deficiency in children with epilepsy: Do we need to detect and treat it?

Journal of Pediatric Neurosciences

Volumn 8, Issue 1, 2013, Pages 5-10

  Harijan, Pooja ^a   Khan, Arif ^a   Hussain, Nahin ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bone; epilepsy; vitamin D

Indexed keywords

ANTICONVULSIVE AGENT; CALCITRIOL; CALCIUM; CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; VALPROIC ACID; VITAMIN D;

ANTICONVULSANT THERAPY; BENIGN CHILDHOOD EPILEPSY; BLOOD CHEMISTRY; BONE DENSITY; CHILD; CLINICAL TRIAL (TOPIC); COMORBIDITY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; GENERALIZED EPILEPSY; HUMAN; LOW DRUG DOSE; MOBILIZATION; NUTRITION; OBESITY; OUTCOME ASSESSMENT; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; REVIEW; RICKETS; RISK FACTOR; SYMPTOM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84878458093     PISSN: 18171745     EISSN: 19983948     Source Type: Journal    
DOI: 10.4103/1817-1745.111413     Document Type: Review

References (41)

1. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 2009;124:e362-70.
2. Offermann G, Pinto V, Kruse R. Antiepileptic drugs and vitamin D supplementation. Epilepsia 1979;20:3-15.
3. El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati MA. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 2008;43:149-55.
4. Gniatkowska-Nowakowska A. Fractures in epilepsy children. Seizure 2010;19:324-5.
5. Souverein PC, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts T. Incidence of fractures among epilepsy patients: A population-based retrospective cohort study in the General Practice Research Database. Epilepsia 2005;46:304-10.
6. Shellhaas RA, Barks AK, Joshi SM. Prevalence and risk factors for vitamin D insufficiency among children with epilepsy. Pediatr Neurol 2010;42:422-6.
7. Valmadrid C, Voorhees C, Litt B, Schneyer CR. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 2001;58:1369-74.
8. Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, et al. Official Positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 ISCD Position Development Conference. J Clin Densitom 2008;11:75e91.
9. Ranganathan LN, Ramaratnam S. Vitamins for epilepsy (Review): The Cochrane Library. London: John Wiley and Sons, Ltd; 2009.
10. Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan Gel-H. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone. Neurology 2006;67:2005-14.
11. Wagner CL, Greer FR. Section on breast feeding and committee on nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;107:1014-8.
12. Winzenberg T, Powell S, Shaw KA, Jones G. Effects of vitamin D supplementation on bone density in healthy children: Systematic review and meta-analysis. BMJ 2011;342:c7254.
13. Rauchenzauner M, Griesmacher A, Tatarczyk T, Haberlandt E, Strasak A, Zimmerhackl LB, et al. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Dev Med Child Neurol 2010;52:283-8.
14. Cansu A, Yesilkaya E, Serdarǒlu A, Hirfanǒlu TL, Camurdan O, Gülbahar O, et al. Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol 2008;39:266-71.
15. Nettekoven S, Ströhle A, Trunz B, Wolters M, Hoffmann S, Horn R, et al. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr 2008;167:1369-77.
16. Bergqvist AG, Schall JI, Stallings VA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia 2007;48:66-71.
17. Sheth RD, Hermann BP. Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol 2007;37:250-4.
18. Bertoli S, Cardinali S, Veggiotti P, Trentani C, Testolin G, Tagliabue A. Evaluation of nutritional status in children with refractory epilepsy. Nutr J 2006;5:14.
19. Tekgul H, Serdaroglu G, Huseyinov A, Gökben S. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy. J Child Neurol 2006;21:411-4.
20. Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol 2006;35:177-81.
21. Nicolaidou P, Georgouli H, Kotsalis H, Matsinos Y, Papadopoulou A, Fretzayas A, et al. Effects of anticonvulsant therapy on vitamin D status in children: Prospective monitoring study. J Child Neurol 2006;21:205-9.
22. Voudris KA, Attilakos A, Katsarou E, Garoufi A, Dimou S, Skardoutsou A, et al. Early alteration in bone metabolism in epileptic children receiving carbamazepine monotherapy owing to the induction of hepatic drug-metabolizing enzymes. J Child Neurol 2005;20:513-6.
23. Ecevit Ç, Aydǒan A, Kavakli T, Altinöz S. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 2004;31:279-82.
24. Oner N, Kaya M, Karasalihǒlu S, Karaca H, Celtik C, Tütüncüler F. Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health 2004;40:470-3.
25. Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 2002;43:1488-92.
26. Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y, et al. Bone mineral status in ambulatory pediatric patients on long-term antiepileptic drug therapy. Pediatr Int 2002;44:247-53.
27. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-53.
28. Guo CY, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 2001;42:1141-7.
29. Kafali G, Erselcan T, Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila) 1999;38:93-8.
30. Akin R, Okutan V, Sarici U, Altunbas A, Gökçay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998;19:129-31.
31. Baer MT, Kozlowski BW, Blyler EM, Trahms CM, Taylor ML, Hogan MP. Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. Am J Clin Nutr 1997;65:1042-51.
32. Sheth RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995;127:256-62.
33. Chung S, Ahn C. Effects of antiepileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev 1994;16:382-5.
34. Weisman Y, Andriola M, Reiter E, Gruskin A, Root A. Serum concentrations of 25-hydroxy vitamin D in Florida children: Effect of anticonvulsant drugs. South Med J 1979;72:400-1, 408.
35. Winnacker JL, Yeager H, Saunders JA, Russell B, Anast CS. Rickets in children receiving anticonvulsant drugs. Biochemical and hormonal markers. Am J Dis Child 1977;131:286-90.
36. Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R. Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J 1971;4:202-4.
37. Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan Gel-H. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone. Neurology 2006;67:2005-14.
38. Jekovec-Vrhovsek M, Kocijancic A, Prezelj J. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev Med Child Neurol 2000;42:403-5.
39. Fischer MH, Adkins WN Jr, Liebl BH, VanCalcar SC, Marlett JA. Bone status in nonambulant, epileptic, institutionalized youth. Improvement with vitamin D therapy. Clin Pediatr (Phila) 1988;27:499-505.
40. Liakakos D, Papadopoulos Z, Vlachos P, Boviatsi E, Varonos DD. Serum alkaline phosphatase and urinary hydroxyproline values in children receiving phenobarbital with and without vitamin D. J Pediatr 1975;87:291-6.
41. Silver J, Davies TJ, Kupersmitt E, Orme M, Petrie A, Vajda F. Prevalence and treatment of vitamin D deficiency in children on anticonvulsant drugs. Arch Dis Child 1974;49:344-50.